Taiwan · Delayed Price · Currency is TWD Beiley Biofund Statistics
Total Valuation
Beiley Biofund has a market cap or net worth of TWD 4.13 billion. The enterprise value is 2.99 billion.
| Market Cap | 4.13B |
| Enterprise Value | 2.99B |
Important Dates
| Earnings Date | n/a |
| Ex-Dividend Date | n/a |
Share Statistics
Beiley Biofund has 205.28 million shares outstanding. The number of shares has increased by 0.04% in one year.
| Current Share Class | 205.28M |
| Shares Outstanding | 205.28M |
| Shares Change (YoY) | +0.04% |
| Shares Change (QoQ) | +0.09% |
| Owned by Insiders (%) | 2.93% |
| Owned by Institutions (%) | 2.41% |
| Float | 148.74M |
Valuation Ratios
The trailing PE ratio is 3.67.
| PE Ratio | 3.67 |
| Forward PE | n/a |
| PS Ratio | 3.36 |
| PB Ratio | 1.25 |
| P/TBV Ratio | 1.25 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 2.66 |
| EV / Sales | 2.44 |
| EV / EBITDA | 2.59 |
| EV / EBIT | 2.59 |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 10.29, with a Debt / Equity ratio of 0.00.
| Current Ratio | 10.29 |
| Quick Ratio | 10.28 |
| Debt / Equity | 0.00 |
| Debt / EBITDA | 0.00 |
| Debt / FCF | -0.15 |
| Interest Coverage | 88,841.92 |
Financial Efficiency
Return on equity (ROE) is 40.70% and return on invested capital (ROIC) is 50.82%.
| Return on Equity (ROE) | 40.70% |
| Return on Assets (ROA) | 25.35% |
| Return on Invested Capital (ROIC) | 50.82% |
| Return on Capital Employed (ROCE) | 34.81% |
| Weighted Average Cost of Capital (WACC) | n/a |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | 0.43 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, Beiley Biofund has paid 47.09 million in taxes.
| Income Tax | 47.09M |
| Effective Tax Rate | 4.02% |
Stock Price Statistics
| Beta (5Y) | n/a |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | 22.19 |
| 200-Day Moving Average | n/a |
| Relative Strength Index (RSI) | 19.61 |
| Average Volume (20 Days) | 204,027 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Beiley Biofund had revenue of TWD 1.23 billion and earned 1.13 billion in profits. Earnings per share was 5.48.
| Revenue | 1.23B |
| Gross Profit | 1.23B |
| Operating Income | 1.15B |
| Pretax Income | 1.17B |
| Net Income | 1.13B |
| EBITDA | 1.16B |
| EBIT | 1.15B |
| Earnings Per Share (EPS) | 5.48 |
Balance Sheet
The company has 1.14 billion in cash and 5.46 million in debt, with a net cash position of 1.13 billion or 5.51 per share.
| Cash & Cash Equivalents | 1.14B |
| Total Debt | 5.46M |
| Net Cash | 1.13B |
| Net Cash Per Share | 5.51 |
| Equity (Book Value) | 3.31B |
| Book Value Per Share | 16.14 |
| Working Capital | 1.03B |
Cash Flow
In the last 12 months, operating cash flow was -35.32 million and capital expenditures -81,000, giving a free cash flow of -35.40 million.
| Operating Cash Flow | -35.32M |
| Capital Expenditures | -81,000 |
| Depreciation & Amortization | 1.49M |
| Net Borrowing | -1.06M |
| Free Cash Flow | -35.40M |
| FCF Per Share | -0.17 |
Margins
Gross margin is 100.00%, with operating and profit margins of 94.11% and 91.72%.
| Gross Margin | 100.00% |
| Operating Margin | 94.11% |
| Pretax Margin | 95.55% |
| Profit Margin | 91.72% |
| EBITDA Margin | 94.23% |
| EBIT Margin | 94.11% |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 1.40, which amounts to a dividend yield of 6.97%.
| Dividend Per Share | 1.40 |
| Dividend Yield | 6.97% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | 2.74% |
| Buyback Yield | -0.04% |
| Shareholder Yield | 6.91% |
| Earnings Yield | 27.28% |
| FCF Yield | -0.86% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Beiley Biofund has an Altman Z-Score of 31.92 and a Piotroski F-Score of 2.
| Altman Z-Score | 31.92 |
| Piotroski F-Score | 2 |